← Back to Clinical Trials
Recruiting NCT07814703

NCT07814703 Intercostobrachial Nerve Block vs Erector Spinae Block for Medial Arm A-V Fistula Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07814703
Status Recruiting
Phase —
Sponsor Fayoum University Hospital
Condition Surgical Anesthesia
Study Type INTERVENTIONAL
Enrollment 158 participants
Start Date 2026-04-01
Primary Completion 2027-04-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
intercostobrachial nerve blockultrasound-guided erector spinae plane block

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 158 participants in total. It began in 2026-04-01 with a primary completion date of 2027-04-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Comparison Between Ultrasound-guided Intercostobrachial Nerve Block with Supraclavicular Block versus Ultrasound -guided Erector Spinae block with Supraclavicular Block for Medial Arm A-V Fistula Surgery

Eligibility Criteria

Inclusion Criteria: * ESRD patient undergoing creation AVF in the medial side of the arm. Exclusion Criteria: * 1\. Patient refusal 2. Drug allergies 3. Body Mass Index of 35 kg/m² or more 4. Coagulation abnormalities 5. Severe heart, kidney, and liver diseases, 6. Pregnancy 7. Vasculitis 8. Unstable hemodynamics 9. Upper extremity neuropathy 10. Mental illness 11. Seizures 12. Contralateral chest problems 13. Infection at site of injection

Contact & Investigator

Central Contact

taghreed shabaan korany, assistant lecturer

✉ Taghreedshaban60@gmail.com

📞 00201007195396

Principal Investigator

mohamed ahmed Ismail, professor

STUDY CHAIR

Faculty of medicine,Fayoum University

Frequently Asked Questions

Who can join the NCT07814703 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Surgical Anesthesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07814703 currently recruiting?

Yes, NCT07814703 is actively recruiting participants. Contact the research team at Taghreedshaban60@gmail.com for enrollment information.

Where is the NCT07814703 trial being conducted?

This trial is being conducted at Al Fayyum, Egypt.

Who is sponsoring the NCT07814703 clinical trial?

NCT07814703 is sponsored by Fayoum University Hospital. The principal investigator is mohamed ahmed Ismail, professor at Faculty of medicine,Fayoum University. The trial plans to enroll 158 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology